The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Development and characterization of novel erythropoiesis stimulating protein (NESP)
Open accessAbstract
Studies on human erythropoietin (EPO) demonstrated that there is a direct relationship between the sialic acid-containing carbohydrate content of the molecule and its serum half-life and in vivo biological activity, but an inverse relationship with its receptor-binding affinity. These observations led to the hypothesis that increasing the carbohydrate content, beyond that found naturally, would lead to a molecule with enhanced biological activity. Hyperglycosylated recombinant human EPO (rHuEPO) analogues were developed to test this hypothesis. Darbepoetin alfa (novel erythropoiesis stimulating protein, NESP, ARANESP, Amgen Inc, Thousand Oaks, CA), which was engineered to contain 5 N-linked carbohydrate chains (two more than rHuEPO), has been evaluated in preclinical animal studies. Due to its increased sialic acid-containing carbohydrate content, NESP is biochemically distinct from rHuEPO, having an increased molecular weight and greater negative charge. Compared with rHuEPO, it has an approximate 3-fold longer serum half-life, greater in vivo potency, and can be administered less frequently to obtain the same biological response. NESP is currently being evaluated in human clinical trials for treatment of anaemia and reduction in its incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Self-citationWinearls, C., Pippard, M., Downing, M., Oliver, D., Reid, C., & Mary Cotes, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92192-6 · Cited by 1,401
Kalantar-Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,148
Purification of human erythropoietin.
Miyake, T., Kung, C. K., & Goldwasser, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)63387-9 · Cited by 886
Eschbach, J. W., Abdulhadi, M. H., Browne, J. K., Delano, B. G., Downing, M. R., Egrie, J. C., Evans, R. W., Friedman, E. A., Graber, S. E., Haley, N. R., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-992 · Cited by 795
Self-citationExpression cloning of the murine erythropoietin receptor
D'Andrea, A. D., Lodish, H. F., & Wong, G. G. (1989) · Cell · doi:10.1016/0092-8674(89)90965-3 · Cited by 738
Efficiency of signalling through cytokine receptors depends critically on receptor orientation
Syed, R. S., Reid, S. W., Li, C., Cheetham, J. C., Aoki, K. H., Liu, B., Zhan, H., Osslund, T. D., Chirino, A. J., Zhang, J., et al. (1998) · Nature · doi:10.1038/26773 · Cited by 551
Self-citationSasaki, H., Bothner, B., Dell, A., & Fukuda, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45317-3 · Cited by 484
Skehel, J. J., Stevens, D. J., Daniels, R. S., Douglas, A. R., Knossow, M., Wilson, I. A., & Wiley, D. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1779 · Cited by 444
MACDOUGALL, I. C., GRAY, S. J., ELSTON, O., BREEN, C., JENKINS, B., BROWNE, J., & EGRIE, J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112392 · Cited by 433
Self-citationEvans, R. W. (1990) · JAMA · doi:10.1001/jama.263.6.825 · Cited by 406
Survival of recombinant erythropoietin in the circulation: the role of carbohydrates
Fukuda, M., Sasaki, H., Lopez, L., & Fukuda, M. (1989) · Blood · doi:10.1182/blood.v73.1.84.84 · Cited by 387
Structural characterization of human erythropoietin.
Lai, P. H., Everett, R., Wang, F. F., Arakawa, T., & Goldwasser, E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35756-3 · Cited by 379
Takeuchi, M., Takasaki, S., Miyazaki, H., Kato, T., Hoshi, S., Kochibe, N., & Kobata, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68975-6 · Cited by 307
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Cazzola, M., Mercuriali, F., & Brugnara, C. (1997) · Blood · doi:10.1182/blood.v89.12.4248 · Cited by 262
Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells
Davis, J. M., Arakawa, T., Strickland, T. W., & Yphantis, D. A. (1987) · Biochemistry · doi:10.1021/bi00383a034 · Cited by 253
Characterization and Biological Effects of Recombinant Human Erythropoietin
Egrie, J. C., Strickland, T. W., Lane, J., Aoki, K., Cohen, A. M., Smalling, R., Trail, G., Lin, F. K., Browne, J. K., & Hines, D. K. (1986) · Immunobiology · doi:10.1016/s0171-2985(86)80101-2 · Cited by 245
Self-citationLacombe, C., & Mayeux, P. (1998) · PubMed · Cited by 242
The Role of Carbohydrate in Erythropoietin Action*
DORDAL, M. S., WANG, F. F., & GOLDWASSER, E. (1985) · Endocrinology · doi:10.1210/endo-116-6-2293 · Cited by 239
Dubé, S., Fisher, J. W., & Powell, J. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77865-x · Cited by 230
Krantz, S. B. (1991) · PubMed · Cited by 219
Recny, M. A., Scoble, H. A., & Kim, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45504-4 · Cited by 210
Glycosylation of recombinant protein therapeutics: control and functional implications
Cumming, D. A. (1991) · Glycobiology · doi:10.1093/glycob/1.2.115 · Cited by 207
On the Mechanism of Erythropoietin-induced Differentiation
Goldwasser, E., Kung, C. K.-H., & Eliason, J. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42503-9 · Cited by 198
The in vivo metabolism of recombinant human erythropoietin in the rat
Spivak, J., & Hogans, B. (1989) · Blood · doi:10.1182/blood.v73.1.90.90 · Cited by 196
The effect of carbohydrate on the structure and stability of erythropoietin.
Narhi, L. O., Arakawa, T., Aoki, K. H., Elmore, R., Rohde, M. F., Boone, T., & Strickland, T. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54457-4 · Cited by 195
NMR structure of human erythropoietin and a comparison with its receptor bound conformation
Cheetham, J. C., Smith, D. M., Aoki, K. H., Stevenson, J. L., Hoeffel, T. J., Syed, R. S., Egrie, J., & Harvey., T. S. (1998) · Nature Structural Biology · doi:10.1038/2302 · Cited by 181
Self-citationRole of sugar chains in the expression of the biological activity of human erythropoietin.
Higuchi, M., Oh-eda, M., Kuboniwa, H., Tomonoh, K., Shimonaka, Y., & Ochi, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42572-0 · Cited by 169
Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins
Tsuda, E., Goto, M., Murakami, A., Akai, K., Ueda, M., Kawanishi, G., Sasaki, R., Chiba, H., & Ishihara, H. (1988) · Biochemistry · doi:10.1021/bi00415a038 · Cited by 156
Sasaki, H., Ochi, N., Dell, A., & Fukuda, M. (1988) · Biochemistry · doi:10.1021/bi00423a017 · Cited by 122
Erythropoietin: Gene Cloning, Protein Structure, and Biological PropertiesPreprint
Browne, J. K., Cohen, A. M., Egrie, J. C., Lai, P., Lin, F. K., Strickland, T. W., Watson, E., & STEBBING, N. (1986) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1986.051.01.082 · Cited by 109
Self-citationInactivation of Erythropoietin by Neuraminidase and by Mild Substitution Reactions
Lowy, P. H., Keighley, G., & Borsook, H. (1960) · Nature · doi:10.1038/185102a0 · Cited by 99
Markham, A., & Bryson, H. M. (1995) · Drugs · doi:10.2165/00003495-199549020-00008 · Cited by 98
Broudy, V. C., Lin, N., Egrie, J. C., de Haën, C., Weiss, T. L., PAPAYANNOPOULOU, T., & Adamson, J. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6513 · Cited by 94
Self-citationS7.7 The role of carbohydrate on the biological activity of erythropoietin
Egrie, J. C., Grant, J. R., Gillies, D. K., Aoki, K. H., & Strickland, T. W. (1993) · Glycoconjugate Journal · doi:10.1007/bf01209934 · Cited by 75
Self-citationStudies on the Role of Sialic Acid in the Physical and Biological Properties of Erythropoietin
Lukowsky, W. A., & Painter, R. H. (1972) · Canadian Journal of Biochemistry · doi:10.1139/o72-127 · Cited by 69
Sowade, B., Sowade, O., Möcks, J., Franke, W. W., & Warnke, H. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.2.303 · Cited by 46
The Erythropoietin Receptor: Biogenesis, Dimerization, and Intracellular Signal TransductionPreprint
Lodish, H. F., Hilton, D. J., Klingmüller, U., Watowich, S. S., & Wu, H. (1995) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1995.060.01.012 · Cited by 33
Elliott, S. G., Lorenzini, T., Strickland, T. W., Delorme, E., & Egrie, J. C. (2000) · Cited by 16
Self-citationThe Molecular Biology of Erythropoietin
Lin, F. (1987) · Springer eBooks · doi:10.1007/978-3-642-72652-1_5 · Cited by 14
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Erythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Optimal and consistent protein glycosylation in mammalian cell culture
Hossler, P., Khattak, S. F., & Li, Z. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp079 · Cited by 669
Glycoprotein Synthesis: An Update
Gamblin, D. P., Scanlan, E. M., & Davis, B. G. (2009) · Chemical Reviews · doi:10.1021/cr078291i · Cited by 596
Metadata
- Authors
- Egrie, J. C., & Browne, J. K.
- Venue
- British Journal of Cancer
- Published
- 2001
- Volume
- 84
- Issue
- s1
- Pages
- 3-10
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2145908121
- Cited by
- 510
- References
- 41
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.